REGENERX BIOPHARMACEUTICALS INC (RGRX) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 40 transactions totaling $7.1M, demonstrating a bullish sentiment with $1.8M in net insider flow. The most recent transaction on Dec 8, 2021 involved a transaction of 130,000 shares valued at $0.
No significant insider buying has been recorded for RGRX in the recent period.
No significant insider selling has been recorded for RGRX in the recent period.
Based on recent SEC filings, insider sentiment for RGRX is bullish with an Insider Alignment Score of 63/100 and a net flow of $1.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at REGENERX BIOPHARMACEUTICALS INC (RGRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading RGRX stock, having executed 40 transactions in the past 90 days. The most active insider is Francesca Cavazza (Executive), who has made 2 transactions totaling $4.1M.
Get notified when executives and directors at RGRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 8, 2021 | L. Goldstein Allan | Executive | Gift | 130,000 | $N/A | $0 | |
| Jun 30, 2021 | Cavazza Paolo | Executive | Purchase | 1,500,000 | $0.20 | $300.0K | |
| Jun 30, 2021 | L. Goldstein Allan | Executive | Purchase | 125,000 | $0.20 | $25.0K | |
| Jun 30, 2021 | J. Finkelstein J. | Executive | Purchase | 75,000 | $0.20 | $15.0K | |
| Feb 13, 2020 | L. Goldstein Allan | Executive | Gift | 200,000 | $N/A | $0 | |
| Jun 12, 2019 | L. Goldstein Allan | Executive | Gift | 228,000 | $N/A | $0 | |
| Jan 6, 2019 | C. Mcnay Joseph | Executive | Conversion | 522,280 | $0.06 | $31.3K | |
| Jan 6, 2019 | L. Goldstein Allan | Executive | Conversion | 208,912 | $0.06 | $12.5K | |
| Sep 27, 2018 | Essetifin Spa | Executive | Conversion | 3,133,681 | $0.06 | $188.0K | |
| Sep 11, 2018 | L. Goldstein Allan | Executive | Conversion | 229,803 | $0.06 | $13.8K | |
| Sep 11, 2018 | C. Mcnay Joseph | Executive | Conversion | 2,089,120 | $0.06 | $125.3K | |
| Sep 11, 2018 | Don Elsey R. | Executive | Conversion | 104,456 | $0.06 | $6.3K | |
| Jul 5, 2018 | C. Mcnay Joseph | Executive | Conversion | 1,044,560 | $0.06 | $62.7K | |
| Jul 5, 2018 | L. Goldstein Allan | Executive | Conversion | 208,912 | $0.06 | $12.5K | |
| Jul 5, 2018 | J. Finkelstein J. | Executive | Conversion | 104,456 | $0.06 | $6.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $4.5M | 43.9% |
Sale(S) | 1 | $2.7M | 26.2% |
Exercise (Options)(X) | 5 | $2.4M | 23.3% |
Conversion(C) | 15 | $678.1K | 6.7% |
Gift(G) | 11 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Insiders at REGENERX BIOPHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 10 insiders making 40 transactions totaling $4.5M in purchases versus $2.7M in sales, the net buying activity of $1.8M signals strong executive confidence. Francesca Cavazza (Executive) leads the buying activity with $4.1M in transactions across all time.